Nantahala Capital Management
Latest statistics and disclosures from Nantahala Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IWM, PTON, HLF, HGV, SLNO, and represent 34.02% of Nantahala Capital Management's stock portfolio.
- Added to shares of these 10 stocks: PTON (+$75M), QURE (+$35M), TBBK (+$23M), SLNO (+$23M), MLYS (+$21M), AVR (+$17M), VSTM (+$17M), CWH (+$15M), PCVX (+$14M), AgomAb Therapeutics NV (+$13M).
- Started 17 new stock positions in AgomAb Therapeutics NV, RVMD, Noodles & Co, CZR, CRIS, DMRA, DUOL, COOK, FORR, Helix Acquisition Corp Iii. POCI, COCH, JANX, ALEC, TRDA, VENU, RLYB.
- Reduced shares in these 10 stocks: IWM (-$190M), EW (-$80M), TNGX (-$49M), EB (-$31M), TEVA (-$30M), DNTH (-$26M), RAPT (-$26M), HLF (-$25M), GMED (-$20M), LYV (-$19M).
- Sold out of its positions in ANEB, Astria Therapeutics, CMCO, CMPS, CNTX, QNCX, EDSA, EB, GMED, GDEN. KZR, KPRX, LYV, LUCD, CASH, NKTR, NPCE, NDLS, NUVB.WS, RAPT, SSKN, SRZN.
- Nantahala Capital Management was a net seller of stock by $-194M.
- Nantahala Capital Management has $2.7B in assets under management (AUM), dropping by -10.20%.
- Central Index Key (CIK): 0001472322
Tip: Access up to 7 years of quarterly data
Positions held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Nantahala Capital Management
Nantahala Capital Management holds 137 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 18.7 | $508M | -27% | 2.1M | 248.00 |
|
| Peloton Interactive Cl A Com (PTON) | 4.7 | $128M | +140% | 30M | 4.29 |
|
| Herbalife Com Shs (HLF) | 3.8 | $102M | -19% | 7.0M | 14.72 |
|
| Hilton Grand Vacations (HGV) | 3.7 | $101M | 2.6M | 39.12 |
|
|
| Soleno Therapeutics (SLNO) | 3.1 | $84M | +37% | 2.5M | 33.48 |
|
| Ban (TBBK) | 3.0 | $81M | +40% | 1.5M | 53.73 |
|
| Viatris Call Option (VTRS) | 2.5 | $68M | 5.0M | 13.51 |
|
|
| Edwards Lifesciences Put Option (EW) | 2.4 | $64M | -55% | 800k | 80.08 |
|
| Bioventus Com Cl A (BVS) | 2.1 | $56M | 6.1M | 9.13 |
|
|
| Establishment Labs Holdings Ord (ESTA) | 1.7 | $47M | -15% | 833k | 56.78 |
|
| Uniqure Nv SHS (QURE) | 1.7 | $46M | +305% | 2.8M | 16.35 |
|
| Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA) | 1.7 | $45M | -40% | 1.5M | 30.12 |
|
| Savara (SVRA) | 1.5 | $40M | 7.3M | 5.46 |
|
|
| Spdr Series Trust State Street Spd Put Option (XBI) | 1.4 | $38M | -25% | 300k | 127.73 |
|
| Xtant Med Hldgs Com New (XTNT) | 1.4 | $38M | 68M | 0.56 |
|
|
| Fox Factory Hldg (FOXF) | 1.4 | $38M | +4% | 2.3M | 16.46 |
|
| Camping World Hldgs Cl A (CWH) | 1.3 | $36M | +71% | 5.3M | 6.83 |
|
| Gogo (GOGO) | 1.3 | $36M | +30% | 8.9M | 4.02 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.3 | $35M | +16% | 2.8M | 12.43 |
|
| Ridenow Group Com Cl B (RDNW) | 1.3 | $35M | 5.0M | 7.06 |
|
|
| Regeneron Pharmaceuticals Call Option (REGN) | 1.1 | $31M | 40k | 772.64 |
|
|
| Anteris Technologies Global (AVR) | 1.1 | $31M | +118% | 5.5M | 5.55 |
|
| Eton Pharmaceuticals (ETON) | 1.1 | $29M | 1.2M | 24.68 |
|
|
| Abeona Therapeutics Com New (ABEO) | 1.0 | $27M | +10% | 6.0M | 4.48 |
|
| Evolus (EOLS) | 1.0 | $26M | +9% | 6.4M | 4.11 |
|
| Tango Therapeutics (TNGX) | 1.0 | $26M | -64% | 1.3M | 20.92 |
|
| Lb Pharmaceuticals Com Shs (LBRX) | 1.0 | $26M | +55% | 1.1M | 24.66 |
|
| Mineralys Therapeutics (MLYS) | 0.9 | $24M | +690% | 896k | 27.09 |
|
| Zevra Therapeutics Com New (ZVRA) | 0.9 | $24M | +42% | 2.5M | 9.32 |
|
| Fulcrum Therapeutics (FULC) | 0.9 | $23M | -28% | 3.1M | 7.67 |
|
| Fossil (FOSL) | 0.9 | $23M | +6% | 5.4M | 4.31 |
|
| Adc Therapeutics Sa SHS (ADCT) | 0.8 | $21M | +2% | 5.6M | 3.75 |
|
| Titan Machinery (TITN) | 0.8 | $21M | +2% | 1.3M | 16.72 |
|
| Imax Corp Cad (IMAX) | 0.7 | $20M | +8% | 516k | 38.01 |
|
| Verastem Com New (VSTM) | 0.7 | $19M | +675% | 3.6M | 5.30 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.7 | $19M | +46% | 2.0M | 9.52 |
|
| Avalo Therapeutics Com New (AVTX) | 0.7 | $18M | 1.2M | 14.93 |
|
|
| Rmr Group Cl A (RMR) | 0.7 | $18M | 1.1M | 15.47 |
|
|
| Rayonier Advanced Matls (RYAM) | 0.7 | $18M | -11% | 1.6M | 11.07 |
|
| Align Technology Call Option (ALGN) | 0.6 | $17M | 100k | 171.43 |
|
|
| Geron Corporation (GERN) | 0.6 | $17M | +24% | 11M | 1.49 |
|
| Vaxcyte (PCVX) | 0.6 | $16M | +678% | 274k | 58.11 |
|
| Benitec Biopharma Com New (BNTC) | 0.6 | $15M | +38% | 1.4M | 10.65 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.6 | $15M | -10% | 137k | 111.35 |
|
| Integer Hldgs (ITGR) | 0.6 | $15M | +68% | 172k | 88.00 |
|
| Rh (RH) | 0.6 | $15M | +22% | 108k | 139.82 |
|
| Keros Therapeutics (KROS) | 0.6 | $15M | +122% | 1.4M | 11.04 |
|
| Chime Finl Com Shs Cl A (CHYM) | 0.6 | $15M | +33% | 800k | 18.73 |
|
| Jack in the Box (JACK) | 0.5 | $15M | +78% | 1.5M | 9.67 |
|
| Jefferson Capital (JCAP) | 0.5 | $14M | +25% | 750k | 19.23 |
|
| Aura Biosciences (AURA) | 0.5 | $14M | 2.1M | 6.69 |
|
|
| USANA Health Sciences (USNA) | 0.5 | $14M | +38% | 810k | 17.47 |
|
| MiMedx (MDXG) | 0.5 | $13M | +40% | 3.4M | 3.95 |
|
| Assertio Holdings Com New (ASRT) | 0.5 | $13M | +17% | 692k | 19.06 |
|
| Lawson Products (DSGR) | 0.5 | $13M | +49% | 495k | 26.24 |
|
| Agomab Therapeutics Nv Sponsored Ads | 0.5 | $13M | NEW | 1.2M | 10.71 |
|
| Helix Acquisition Corp Iii Usd Cl A Ord Shs | 0.5 | $13M | NEW | 1.3M | 10.16 |
|
| Apyx Medical Corporation (APYX) | 0.5 | $13M | -13% | 3.4M | 3.69 |
|
| Silence Therapeutics Ads (SLN) | 0.4 | $11M | +39% | 2.1M | 5.27 |
|
| Janux Therapeutics (JANX) | 0.4 | $11M | NEW | 810k | 13.90 |
|
| Monte Rosa Therapeutics (GLUE) | 0.4 | $11M | +1024% | 652k | 16.45 |
|
| 1 800 Flowers Cl A (FLWS) | 0.4 | $10M | 3.4M | 3.04 |
|
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $10M | 255k | 39.72 |
|
|
| X4 Pharmaceuticals Com New (XFOR) | 0.4 | $10M | 2.4M | 4.13 |
|
|
| Duolingo Cl A Com (DUOL) | 0.4 | $9.9M | NEW | 100k | 98.57 |
|
| Cogent Biosciences (COGT) | 0.4 | $9.6M | 250k | 38.49 |
|
|
| Service Pptys Tr Com Sh Ben Int (SVC) | 0.4 | $9.6M | 7.1M | 1.35 |
|
|
| Industrial Logistics Pptys T Com Shs Ben Int (ILPT) | 0.4 | $9.5M | 1.7M | 5.68 |
|
|
| Reservoir Media (RSVR) | 0.3 | $9.2M | 941k | 9.79 |
|
|
| Solid Biosciences Com New (SLDB) | 0.3 | $8.4M | -27% | 1.2M | 7.20 |
|
| Trisalus Life Sciences (TLSI) | 0.3 | $8.3M | 2.1M | 4.00 |
|
|
| America's Car-Mart (CRMT) | 0.3 | $8.2M | 645k | 12.73 |
|
|
| Viemed Healthcare (VMD) | 0.3 | $8.1M | -5% | 884k | 9.21 |
|
| Ocuphire Pharma (IRD) | 0.3 | $7.7M | -64% | 1.7M | 4.55 |
|
| Korro Bio (KRRO) | 0.3 | $7.5M | +10% | 660k | 11.32 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.3 | $7.4M | -35% | 536k | 13.90 |
|
| Damora Therapeutics Com New (DMRA) | 0.3 | $7.2M | NEW | 278k | 25.90 |
|
| Lexeo Therapeutics (LXEO) | 0.3 | $6.9M | +20% | 1.2M | 5.74 |
|
| Venu Hldg Corp (VENU) | 0.2 | $6.8M | NEW | 2.0M | 3.31 |
|
| Codexis (CDXS) | 0.2 | $6.7M | +3% | 4.1M | 1.63 |
|
| Dhi (DHX) | 0.2 | $6.7M | 2.4M | 2.81 |
|
|
| Unicycive Therapeutics Com New (UNCY) | 0.2 | $6.2M | 939k | 6.58 |
|
|
| Fractyl Health (GUTS) | 0.2 | $6.1M | +23% | 13M | 0.46 |
|
| Alector (ALEC) | 0.2 | $6.1M | NEW | 2.8M | 2.15 |
|
| Hain Celestial (HAIN) | 0.2 | $6.0M | +30% | 8.5M | 0.70 |
|
| Dianthus Therapeutics (DNTH) | 0.2 | $5.6M | -82% | 67k | 83.92 |
|
| Inspiremd (NSPR) | 0.2 | $5.5M | 3.4M | 1.63 |
|
|
| Kosmos Energy (KOS) | 0.2 | $5.1M | -21% | 1.8M | 2.78 |
|
| Envoy Medical Cl A (COCH) | 0.2 | $5.1M | NEW | 7.7M | 0.67 |
|
| Alta Equipment Group Common Stock (ALTG) | 0.2 | $5.0M | 935k | 5.37 |
|
|
| Dariohealth Corp (DRIO) | 0.2 | $4.9M | +8% | 611k | 8.02 |
|
| Revolution Medicines (RVMD) | 0.2 | $4.9M | NEW | 50k | 97.25 |
|
| Noodles & Co Cl A New | 0.2 | $4.7M | NEW | 554k | 8.55 |
|
| Inhibikase Therapeutics Com New (IKT) | 0.2 | $4.5M | -31% | 2.7M | 1.68 |
|
| Mara Holdings Note 3/0 (Principal) | 0.2 | $4.4M | 5.0M | 0.89 |
|
|
| Disc Medicine (IRON) | 0.2 | $4.3M | -49% | 67k | 63.94 |
|
| Caesars Entertainment (CZR) | 0.1 | $4.0M | NEW | 150k | 26.43 |
|
| Forrester Research (FORR) | 0.1 | $3.9M | NEW | 694k | 5.66 |
|
| One Group Hospitality In (STKS) | 0.1 | $3.8M | 2.1M | 1.78 |
|
|
| Tela Bio (TELA) | 0.1 | $3.7M | 5.9M | 0.62 |
|
|
| Upstream Bio (UPB) | 0.1 | $3.6M | -19% | 400k | 9.00 |
|
| NN (NNBR) | 0.1 | $3.5M | 2.4M | 1.45 |
|
|
| Acasti Pharma (GRCE) | 0.1 | $3.4M | -38% | 728k | 4.63 |
|
| Cg Oncology (CGON) | 0.1 | $3.3M | -54% | 49k | 67.68 |
|
| Elutia Cl A Com (ELUT) | 0.1 | $3.3M | 3.2M | 1.05 |
|
|
| Xencor (XNCR) | 0.1 | $3.2M | +60% | 265k | 12.06 |
|
| Arvinas Ord (ARVN) | 0.1 | $3.2M | 300k | 10.60 |
|
|
| Orthopediatrics Corp. (KIDS) | 0.1 | $3.2M | 199k | 15.87 |
|
|
| Traeger Com New (COOK) | 0.1 | $3.0M | NEW | 102k | 29.00 |
|
| Aytu Biopharma (AYTU) | 0.1 | $3.0M | 1.1M | 2.73 |
|
|
| Scully Royalty Com Shs (SRL) | 0.1 | $2.9M | 368k | 7.82 |
|
|
| Immunic (IMUX) | 0.1 | $2.8M | -42% | 2.5M | 1.11 |
|
| Akebia Therapeutics (AKBA) | 0.1 | $2.8M | 2.0M | 1.39 |
|
|
| Rallybio Corp (RLYB) | 0.1 | $2.7M | NEW | 301k | 8.97 |
|
| Talphera Com New (TLPH) | 0.1 | $2.6M | 3.5M | 0.75 |
|
|
| Gaia Cl A (GAIA) | 0.1 | $2.5M | 915k | 2.77 |
|
|
| Payoneer Global (PAYO) | 0.1 | $2.3M | 484k | 4.83 |
|
|
| eHealth (EHTH) | 0.1 | $2.3M | 1.8M | 1.29 |
|
|
| Reading Intl Cl A (RDI) | 0.1 | $2.2M | 1.9M | 1.13 |
|
|
| Destination Xl (DXLG) | 0.1 | $2.1M | -8% | 4.1M | 0.51 |
|
| BRC Com Cl A (BRCC) | 0.1 | $2.0M | 2.6M | 0.78 |
|
|
| Entrada Therapeutics (TRDA) | 0.1 | $2.0M | NEW | 159k | 12.62 |
|
| Achieve Life Sciences (ACHV) | 0.1 | $1.9M | 649k | 2.94 |
|
|
| Precision Optics Corp Inc Ma Com New (POCI) | 0.0 | $1.2M | NEW | 280k | 4.39 |
|
| Pepgen (PEPG) | 0.0 | $1.2M | -55% | 681k | 1.77 |
|
| Vyne Therapeutics (VYNE) | 0.0 | $1.2M | +100% | 2.0M | 0.60 |
|
| Curis (CRIS) | 0.0 | $1.1M | NEW | 2.0M | 0.55 |
|
| Perfect Corp Cl A Ord Shs (PERF) | 0.0 | $987k | 584k | 1.69 |
|
|
| Altisource Portfolio Solutio *w Exp 04/30/203 (ASPSW) | 0.0 | $941k | 2.5M | 0.38 |
|
|
| Acme United Corporation (ACU) | 0.0 | $917k | 20k | 44.91 |
|
|
| Senti Biosciences Com New (SNTI) | 0.0 | $721k | 888k | 0.81 |
|
|
| Altisource Portfolio Solutio *w Exp 04/02/202 (ASPSZ) | 0.0 | $496k | 2.5M | 0.20 |
|
|
| Biomx Com New (PHGE) | 0.0 | $431k | 115k | 3.75 |
|
|
| Spar (SGRP) | 0.0 | $413k | 661k | 0.63 |
|
|
| Aprea Therapeutics Com New (APRE) | 0.0 | $157k | 206k | 0.76 |
|
|
| Guardforce Ai *w Exp 10/01/202 (GFAIW) | 0.0 | $9.3k | 154k | 0.06 |
|
|
| Perfect Corp *w Exp 10/28/202 (PERF.WS) | 0.0 | $237.910000 | 16k | 0.01 |
|
Past Filings by Nantahala Capital Management
SEC 13F filings are viewable for Nantahala Capital Management going back to 2011
- Nantahala Capital Management 2026 Q1 filed May 15, 2026
- Nantahala Capital Management 2025 Q4 filed Feb. 13, 2026
- Nantahala Capital Management 2025 Q3 filed Nov. 14, 2025
- Nantahala Capital Management 2025 Q2 filed Aug. 14, 2025
- Nantahala Capital Management 2025 Q1 filed May 15, 2025
- Nantahala Capital Management 2024 Q4 filed Feb. 14, 2025
- Nantahala Capital Management 2024 Q3 filed Nov. 14, 2024
- Nantahala Capital Management 2024 Q2 amended filed Aug. 20, 2024
- Nantahala Capital Management 2024 Q2 filed Aug. 14, 2024
- Nantahala Capital Management 2024 Q1 filed May 15, 2024
- Nantahala Capital Management 2023 Q4 amended filed Feb. 15, 2024
- Nantahala Capital Management 2023 Q4 filed Feb. 14, 2024
- Nantahala Capital Management 2023 Q3 filed Nov. 14, 2023
- Nantahala Capital Management 2023 Q2 filed Aug. 14, 2023
- Nantahala Capital Management 2023 Q1 filed May 15, 2023
- Nantahala Capital Management 2022 Q4 filed Feb. 14, 2023